As India explores different therapies to treat Covid-19, results from the Indian Council of Medical Research’s (ICMR’s) convalescent plasma therapy (CPT) trials are expected in a couple of weeks, claim sources at clinical trial sites.
So far, the results are mixed — while some patients have recovered, there have also been cases of conditions worsening.
The trial, taking place across 50 sites in India, has collected data from 350-odd patients. The sample size for the trial is 425 patients and the results are likely to be announced soon, said a source at a Gujarat-based site. CPT is being used in India on